Contraception
📧 Sign up to get email alerts when something new happens for Contraception.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Right For Me: Birth Control Decisions Made Easier [NA]
Clinical trial update for a contraception study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - United States/Canada Study [Phase 3]
Phase 3 trial update for E4 FREEDOM evaluating estetrol/drospirenone as an oral contraceptive in the US/Canada; study completed with results…
-
FDA approval · 2019-10-28FDA Approved: CYRED EQ — Supplemental Application (Afaxys Pharma, LLC)
The FDA approved a supplemental application for CYRED EQ, a desogestrel/ethinyl estradiol oral contraceptive, submitted by Afaxys Pharma, LL…
-
FDA label_change · 2019-10-28FDA Approved: AZURETTE — Supplemental Application (Mayne Pharma Inc.)
FDA granted a supplemental approval for Azurette, updating its labeling for the desogestrel/ethinyl estradiol combination.
-
CLINICAL_TRIALS trial_result · 2019-10-18Clinical Trial Update: Sayana Press UK Self-Injection Study [Phase 4]
A Phase 4 clinical trial updating Sayana Press self-injection in the UK for contraception has completed, with results posted in 2019.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-10-18Clinical Trial Update: Regulation of Cervical Mucus Secretion [Phase 4]
Phase 4 clinical trial on regulation of cervical mucus secretion completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - EU/Russia Study [Phase 3]
Phase 3 trial update for Estetrol/Drospirenone oral contraceptive (E4 FREEDOM) completed in EU/Russia with posted results.
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: RCT: Can a Single Counseling Phone Call Improve Contraception After an Abortion? [NA]
A completed randomized trial investigated whether a single counseling phone call improves contraception use after abortion.
-
CLINICAL_TRIALS trial_result · 2019-09-18Clinical Trial Update: Depo Provera Self-Administration Study: Putting a Patient-Centered Practice to the Test at Planned Parenthood [Phase 4]
Phase 4 clinical trial evaluating self-administration of Depo-Provera in a patient-centered setting at Planned Parenthood; study completed w…
-
FDA approval · 2019-09-09FDA Approved: MIBELAS 24 FE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin's supplemental application for MIBELAS 24 FE, a norethindrone acetate/ethinyl estradiol/ferrous fumarate combination oral…
-
CLINICAL_TRIALS trial_result · 2019-08-12Clinical Trial Update: A Study to Compare 3 Doses of a Hormonal Intra-uterine Device Containing Levonorgestrel and Indomethacin With a Hormonal Intra-uterine Device Containing Only Levonorgestrel to Assess the Effect and Safety of the Combined Components [Phase 2]
A Phase 2 trial comparing three doses of a hormonal intrauterine device with combined levonorgestrel and indomethacin versus a levonorgestre…
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles [Phase 3]
Phase 3 clinical trial update evaluating safety, efficacy, tolerability, and pharmacokinetics of LF111 (drospirenone 4.0 mg) for contracepti…
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Opportunistic Salpingectomy for Permanent Sterilization at the Time of Cesarean Delivery [NA]
Completed clinical trial update on opportunistic salpingectomy at cesarean delivery for permanent contraception.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study
A completed prospective cohort study comparing levonorgestrel IUD and copper IUD placed immediately after placental delivery.
-
CLINICAL_TRIALS trial_result · 2019-06-28Clinical Trial Update: YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China [Phase 4]
Phase 4 clinical trial update for YAZ in China assessing post-authorization safety and efficacy in contraception.
-
CLINICAL_TRIALS trial_result · 2019-06-19Clinical Trial Update: Video Versus Conversational Contraceptive Counseling During Maternity Hospitalization [NA]
A completed clinical trial comparing video versus conversational contraceptive counseling during maternity hospitalization, with results pos…
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: Testing the Impact of Two Posters on Contraceptive Knowledge, Contraceptive Preferences, and Perceived Pregnancy Risk [NA]
A completed clinical trial evaluating the impact of two posters on contraceptive knowledge, preferences, and perceived pregnancy risk.
-
CLINICAL_TRIALS trial_result · 2019-05-31Clinical Trial Update: Protease Inhibitors and Combined Oral Contraceptive Pharmacokinetics and Pharmacodynamics [Phase 4]
Phase 4 trial investigating protease inhibitors and combined oral contraceptive pharmacokinetics/pharmacodynamics was terminated; results po…
-
FDA approval · 2019-05-02FDA Approved: RESTART — Original Application (Winx Health Inc.)
FDA approves Winx Health Inc.'s original application for RESTART (levonorgestrel), bringing a generic contraceptive to market.
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: Immediate Postplacental IUD Insertion [NA]
A terminated clinical trial investigating immediate postplacental IUD insertion for contraception; results posted in 2019.
-
FDA approval · 2019-04-26FDA Approved: NORGESTIMATE AND ETHINYL ESTRADIOL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Norgestimate and Ethinyl Estradiol, a combined oral contraceptive.
-
CLINICAL_TRIALS trial_result · 2019-04-26Clinical Trial Update: The Effect of Nitroglycerin on the Intrauterine Device (IUD) Insertion Experience in Nulliparous Women [NA]
Clinical trial studying nitroglycerin effects on pain and insertion experience during IUD placement in nulliparous women has completed with …
-
FDA approval · 2019-04-03FDA Approved: ESTRADIOL AND NORETHINDRONE ACETATE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved Ingenus Pharmaceuticals' Estradiol and norethindrone acetate as a generic product under ANDA210612.
-
CLINICAL_TRIALS trial_result · 2019-03-28Clinical Trial Update: Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant [Phase 2]
Phase 2 trial update examining interactions between darunavir and rilpivirine with the etonogestrel contraceptive implant in HIV and contrac…
-
FDA approval · 2019-03-22FDA Approved: DROSPIRENONE AND ETHINYL ESTRADIOL — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic drospirenone and ethinyl estradiol combination tablet under an original application (ANDA 21194…